| ESC Rene Laennec Lecture on Clinical Cardiology | | Tendera, Michal (PL)
| | 980-983
|
| New methods to diagnose left ventricular function: non-invasive imaging | | Sicari, Rosa (Italy)
| Non-invasive imaging: Echocardiography, MR/CT, Nuclear | 960000 |
| Imaging to guide therapy in heart failure Symposium | | Perrone-Filardi, Pasquale (Italy)
| Heart Failure (HF) | 955000 |
| Stem cells: from bedside to bench again? -Heart failure | | Leor, Jonathan (Israel)
| Heart Failure (HF) | 948-957
|
| Inflammatory mechanisms in atherosclerosis - genetics | | Tousoulis, Dimitris (Greece)
| Genetics | 948000
|
| Therapeutic potential of nitric oxide (NO) - acute coronary syndromes (ACS) | | Harding, Sian E. (United Kingdom)
| Acute Coronary Syndromes (ACS) | 947000 |
| Lipids, still relevant in 2007-CVD prevention, risk assessment | | Reiner, Zeljko (Croatia)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 946000 |
| Gender (dis)advantages in cardiac remodelling-pregnancy, heart disease | | Doevendans, Pieter (Netherlands)
| Pregnancy and Heart Disease | 934000 |
| Molecular pathology of cardiomyopathies, sudden death-arrhythmia | | Richard, Sylvain (France)
| Arrhythmias | 932000 |
| Percutaneous valve therapy,learn from surgeon-Valvular heart disease | | Maisano, Francesco (Italy)
| Valvular Heart Diseases | 930000 |
| Questions in coronary revascularisation-Ischaemic heart disease | | Torracca, Lucia (Italy)
| Chronic Ischaemic Heart Disease (IHD) | 928000
|
| New perspectives in myocarditis, pericarditis-myocardial disease | | Bilinska, Zofia (Poland)
| Myocardial Disease | 924000 |
| New endpoints, endpoint definition in trials-clinical pharmacology | | Alonso-Pulpon Rivera, Luis (Spain)
| Clinical pharmacology | 915000
|
| How to manage athletes with arrhythmias or related symptoms | | Carre, Francois (France)
| Arrhythmias | 903000
|
| Cardiac rhythm devices, Europe and USA-Sudden cardiac death | | Brugada Terradellas, Josep (Spain)
| Sudden Cardiac Death and Resuscitation | 899-902 |
| Matrix metalloproteinases, cardiovascular pathology-myocardial disease | | Agewall, Stefan (Norway)
| Myocardial Disease | 878 - 881
|
| Therapeutic angiogenesis / arteriogenesis - Ischemic heart disease | | Waltenberger, Johannes (Maastricht, The Netherlands)
| Chronic Ischaemic Heart Disease (IHD) | 866 - 869
|
| New insights into atherosclerosis and vascular injury - ESC & EAS | | Taskinen, Marja-Riitta (Finland)
| | 721000
|
| Young at heart: cardiovascular health-ESC and European Heart Network | | Ryden, Lars (Sweden)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 716 000
|
| The effect of ranolazine-arrhythmia - CLINICAL TRIAL UPDATE 2 | | Scirica, Benjamin Morgan (United States of America)
| Arrhythmias | 4507 |
| Bosentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and post-pulmonary endarterectomy pulmonary hypertension: a subgroup analysis of the randomised, placebo-controlled trial - BENEFiT- CLINICAL TRIAL UPDATE 2 | | Lang, Irene Marthe (Austria)
| Thromboembolic Venous Disease | 4505
|
| COACH-study: results of subgroup analyses-heart failure - CLINICAL TRIAL UPDATE 2 | | Jaarsma, Tiny (Netherlands)
| | 4503 |
| Anti-oxidant AGI-1067(succinobucol) effect on glycaemic control | | Ryden, Lars (Sweden)
| Acute Coronary Syndromes (ACS) | 4501-4502
|
| Focus session: Options for end stage heart failure | | Metra Marco (Brescia, Italy)
| Heart Failure (HF) | 357 - 359
|
| The patient with mild heart failure-prevent disease progression-Focus | | Leclercq, Christophe (Rennes, France)
| Heart Failure (HF) | 353 - 355
|
| Results of the predictors of response to CRT (PROSPECT) trial - - HOTLINE 2 | | Linde, Cecilia (Sweden)
| | 3222 |
| WENBIT trial-Cardiovascular Disease prevention - HOTLINE 2 | | Ebbing, Marta (Norway)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 3220 |
| Excess cardiovascular mortality at 5-year, getABI study - HOTLINE 3 | | Diehm, Curt (Germany) & Poldermans, Don (Netherlands)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 3215 |
| Survey-arrhythmia rate in so-called high-risk MI patients - HOTLINE 1 | | Boriani, Giuseppe (Italy) & Breithardt, Guenter (Germany)
| Arrhythmias | 318 |
| Clinical reality of coronary prevention - EUROASPIRE - HOTLINE 1 | | Wood, David A (UK) & Poole-Wilson, Philip Alexander (UK)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 316 |
| ADVANCE-BP lowering,intensive glucose control-prevention - HOTLINE 1 | | Mac Mahon, Stephen (Australia) & Smith, Sydney C (United States of America)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 312 |
| How to manage co-morbidity, CVD prevention, risk assessment | | Dahlstrom, Ulf Georg (Sweden)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 3117-3120
|
| 3CPO trial-non-invasive ventilation effect-Heart failure - HOTLINE 1 | | Newby, David (United Kingdom)
| Heart Failure (HF) | 310
|
| Collateral circulation, chronic ischaemic heart disease | | Zimarino, Marco (Italy)
| Chronic Ischaemic Heart Disease (IHD) | 3088-3091
|
| Metabolism, key to understand heart disease-heart failure | | Neglia, D (Italy)
| Heart Failure (HF) | 2992-2995 |
| Emerging novel molecular targets in anti-arrhythmic therapy | | Cinca, Juan (Barcelona, Spain)
| Arrhythmias | 2299-2302 |
| Does physical activity,molecular key to longevity-CVD prevention | | Kemi, Ole Johan (United Kingdom)
| Cardiovascular Disease Prevention - Risk Assessment and Management | 2275 - 2278 |
| Exercise training, alterations at the molecular level-Rehabilitation | | Wisloff, Ulrik (Norway)
| Rehabilitation and Exercise Physiology | 179000
|
| Optimal pre-PCI 600mg clopidogrel loading: PRAGUE-8 - HOTLINE 2 | | Widimsky, Petr (Czech Republic)
| Acute Coronary Syndromes (ACS) | 1766 |
| OASIS-5-Worse outcome in women with invasive strategy - HOTLINE 2 | | & Rosengren, Annika (Sweden)
| Acute Coronary Syndromes (ACS) | 1764
|
| Randomised evaluation of routine transfer for urgent PCI or local management for patients admitted with STEMI to centres without PCI facilities intially treated with reteplase, heparin and abciximab (CARESS in AMI) - HOTLINE 2 | | Verheugt, Freek (Nijmegen, Netherlands) & ESC Press Office
| Acute Coronary Syndromes (ACS) | 1763 |
| RIO-Reopro, peripheral arterial intervention, outcome - HOTLINE 2 | | Sievert, Horst (Germany) - Discussant
| Peripheral Arterial Diseases | 1758-1759
|
| Challenges in percutaneous revascularisation in the elderly, ACS | | Lafont, Antoine (France)
| Acute Coronary Syndromes (ACS) | 169000 |
| Atrial fibrillation ablation-new techniques,Meet the experts-arrhythmia | | Adragao, Pedro Pulido (Portugal)
| Arrhythmias | 1624-1627
|
| Safety of Drug-eluting stents-Acute Coronary Syndromes-ACS | | Lafont, Antoine (France)
| Acute Coronary Syndromes (ACS) | 1616-1619 |
| high-risk atherosclerosis- Acute Coronary Syndromes (ACS) | | Erbel, Raimund (Germany)
| Acute Coronary Syndromes (ACS) | 160000
|
| Atherosclerosis is shear stress-Ischaemic Heart Disease | | Tritto, Isabella (Italy)
| Chronic Ischaemic Heart Disease (IHD) | 1568 - 1571
|
| Genetic control of cardiovascular development-State of the art | | Franco Jaime, Diego (Spain)
| Genetics | 148-151
|
| Biomarkers for tailoring of treatment in acute coronary syndromes(ACS) | | Weber, M. (Germany)
| Acute Coronary Syndromes (ACS) | 147000 |
| Modern therapy in pulmonary arterial hypertension Symposium | | Gibbs, Simon (United Kingdom)
| Pulmonary Hypertension | 140000
|
| Challenges in endocarditis Symposium - Infective endocarditis | | Boudoulas, Harisios (Greece)
| Infective Endocarditis | 136000 |
| Aortic Stenosis, Valvular Heart Disease | | Rahimtoola, Shahbudin (United States of America)
| Valvular Heart Diseases | 134000 |
| Importance of exercise training, cardiovascular disease-rehabilitation | | Bigi, Riccardo (Italy)
| Rehabilitation and Exercise Physiology | 120 - 123
|
| Left ventricular dysynchrony in cardiac resynchronisation therapy | | Sitges, Marta (Spain)
| Non-invasive imaging: Echocardiography, MR/CT, Nuclear | 117000
|
| Cardiac resynchronisation therapy: hot news?-heart failure | | Paul, Vincent (United Kingdom)
| Heart Failure (HF) | 115000 |
| Home-monitoring of devices and implantable cardioverter-defibrillators, arrhythmia | | Kraemer, Lars-Immo (Germany)
| Arrhythmias | 111000
|
| Imaging the aorta for decision making - FOCUS Session | | Erbel, Raimund (Essen, DE)
| Diseases of the Aorta and Trauma to the Aorta and Heart | 1101 - 1104 |
| ACUITY:bivalirudin with/without GP IIbIIIa inhibitors - CLINICAL TRIAL UPDATE 1 | | White, Harvey (Auckland, NZ)
| Acute Coronary Syndromes (ACS) | 1031
|
| ISAR-REACT-1 year outcome, abciximab vs placebo NSTE-ACS - CLINICAL TRIAL UPDATE 1 | | Seyfarth, Melchior (Germany)
A. Kastrati, J. Mehilli, F.-J. Neumann, J. ten Berg, O. Bruskina, F. Dotzer, J. Pache, J. Dirschinger, P. B. Berger, A. Schömig
| Acute Coronary Syndromes (ACS) | 1029
|
| ExTRACT-TIMI 25:Enoxaparin vs UF heparin for STEMI - CLINICAL TRIAL UPDATE 1 | | Morrow, David (USA) & Wallentin, Lars (Sweden)
| Acute Coronary Syndromes (ACS) | 1027
|
| 3 year follow-up after sirolimus-eluting vs BMS in AMI - CLINICAL TRIAL UPDATE 1 | | Valgimigli, Marco; Ferrara, (Italy)
| Acute Coronary Syndromes (ACS) | 1023
|
| Long term mortality after drug eluting stents in Sweden - one additional year of follow-up - CLINICAL TRIAL UPDATE 1 | | James, Stefan (Sweden)
| Chronic Ischaemic Heart Disease (IHD) | 1021
|
| Prognostic implications left atrial size, function-non-invasive imaging | | Colonna, Paolo (Bari, Italy)
| Non-invasive imaging: Echocardiography, MR/CT, Nuclear | 962
|
| Echocardiographic diagnosis of LV diastolic dysfunction, imaging | | Van De Veire, Nico (Belgium)
| Non-invasive imaging: Echocardiography, MR/CT, Nuclear | 2996 |
| DANAMI2:fibrinolytic therapy vs primary angioplasty,AMI - CLINICAL TRIAL UPDATE 1 | | Nielsen, Torsten Toftegaard (Denmark) & Steg, Philippe Gabriel
| Acute Coronary Syndromes (ACS) | 1025 |
| STEEPLE,1 year:Enoxaparin vs UF heparin in elective PCI - CLINICAL TRIAL UPDATE 1 | | Montalescot, Gilles (France) & Kristensen, Steen Dalby (Denmark)
| Chronic Ischaemic Heart Disease (IHD) | |